Skip to main content
Home
Shalina

Main navigation

  • Home
User account menu
  • Log in

Download in App

Breadcrumb

  1. Home
Unique Code
1000

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3.

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.

Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.

Paediatricians provide higher quality care to children and adolescents in primary care: A systematic review.

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.

Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.

The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.

Determinants of clinical practice guidelines' utilization for the management of musculoskeletal disorders: a scoping review.

Applying Pharmacogenomic Guidelines to Combat Medical Care.

Pagination

  • Previous page
  • 2
  • Next page
Download in App
RSS feed
Powered by Drupal